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The role of the actin cytoskeleton in regulating mem-
brane protein trafficking is complex and depends on the
cell type and protein being examined. Using the epidid-
ymis as a model system in which luminal acidification is
crucial for sperm maturation and storage, we now re-
port that modulation of the actin cytoskeleton by the
calcium-activated actin-capping and -severing protein
gelsolin plays a key role in regulating vacuolar H-
ATPase (V-ATPase) recycling. Epididymal clear cells
contain abundant V-ATPase in their apical pole, and an
increase in their cell-surface V-ATPase expression cor-
relates with an increase in luminal proton secretion. We
have shown that apical membrane accumulation of V-
ATPase is triggered by an elevation in cAMP following
activation of bicarbonate-regulated soluble adenylyl cy-
clase in response to alkaline luminal pH (Pastor-Soler,
N., Beaulieu, V., Litvin, T. N., Da Silva, N., Chen, Y.,
Brown, D., Buck, J., Levin, L. R., and Breton, S. (2003)
J. Biol. Chem. 278, 49523–49529). Here, we show that
clear cells express high levels of gelsolin, indicating a
potential role in the functional activity of these cells.
When jasplakinolide was used to overcome the severing
action of gelsolin by polymerizing actin, complete inhi-
bition of the alkaline pH- and cAMP-induced apical
membrane accumulation of V-ATPase was observed.
Conversely, when gelsolin-mediated actin filament elon-
gation was inhibited using a 10-residue peptide (PBP10)
derived from the phosphatidylinositol 4,5-bisphosphate-
binding region (phosphoinositide-binding domain 2) of
gelsolin, significant V-ATPase apical membrane mobiliza-
tion was induced, even at acidic luminal pH. In contrast,
the calcium chelator 1,2-bis(2-aminophenoxy)ethane-
N,N,N,N-tetraacetic acid tetrakis(acetoxymethyl ester)
and the phospholipase C inhibitor U-73122 inhibited the
alkaline pH-induced V-ATPase apical accumulation. Thus,
maintenance of the actin cytoskeleton in a depolymerized
state by gelsolin facilitates calcium-dependent apical accu-
mulation of V-ATPase in response to luminal pH alkaliniza-
tion. Gelsolin is present in other cell types that express the
V-ATPase in theirplasmamembraneandrecyclingvesicles,
including kidney intercalated cells and osteoclasts. There-
fore, modulation of the actin cortex by this severing and
capping protein may represent a common mechanism by
which these cells regulate their rate of proton secretion.
The actin cytoskeleton is a dynamic structure that is in-
volved in a variety of cellular processes, including cell motility
(1–6), division (7), adhesion (8), and vesicle trafficking (9–20).
In eukaryotic cells, a dense sheet of polymerized actin adjacent
to the plasma membrane forms the actin cortex. The role of the
cortical actin in regulating vesicle trafficking is extremely com-
plex, and numerous studies have shown that depolymerization
of the actin cytoskeleton can either facilitate or impair vesicle
recycling. This topic has been extensively reviewed (20, 21),
and the following examples illustrate the variability of results
obtained upon actin cytoskeleton modification. Orci et al. (13)
were among the first to demonstrate that the actin-depolymer-
izing agent cytochalasin can either stimulate or inhibit exocy-
tosis depending on the experimental conditions used. Actin
depolymerization enhances catecholamine secretion in adrenal
chromaffin cells (22, 23), suggesting that the actin cortex can
form a barrier for exocytic vesicles. Although a similar stimu-
lation of exocytosis was observed upon moderate actin depoly-
merization in pancreatic acinar cells, severe depletion of F-
actin inhibited exocytosis in these cells (18), indicating the
need for a minimal amount of polymerized actin. In intact
muscle, the insulin-stimulated cell-surface mobilization of
GLUT4 is inhibited after disruption of cortical F-actin (24). In
contrast, accumulation of the water channel AQP2 in the
plasma membrane of primary cultured kidney collecting duct
principal cells occurs after disruption of the actin cytoskeleton
(25). Increase in surface expression of AQP2 is promoted by
vasopressin in the mammalian kidney and toad bladder (26),
and in the latter, this process was shown to be accompanied by
depolymerization of the actin cytoskeleton (27). More recently,
actin filaments were proposed to facilitate endocytosis of water
channels but not to be required for exocytosis in the toad
bladder (28). In some cells, disruption of the actin cytoskeleton
inhibits apical endocytosis without affecting basolateral endo-
cytosis (29, 30). Another study showed variable effects on re-
ceptor-mediated endocytosis after either depolymerization or
polymerization of actin filaments in different cell types (31). It
therefore appears that opposite effects can be obtained follow-
ing disruption of the actin cytoskeleton depending on the cell
type or the nature of the recycling process examined.
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Remodeling of the actin cytoskeleton is controlled by several
intracellular proteins, including the calcium-activated actin-
severing proteins villin, gelsolin, fragmin, severin, and ad-
severin (scinderin) (32, 33). Gelsolin severs actin filaments and
caps their fast-growing barbed ends, thereby promoting rapid
actin filament fragmentation and blocking their elongation (34,
35). The binding of gelsolin to actin is activated by calcium and
by low pH, whereas phosphatidylinositol 4,5-bisphosphate
(PIP2)
1 and some other phosphoinositides remove gelsolin from
the barbed ends of actin filaments (36, 37). Two phosphoinosit-
ide-binding domains (PBDs) of gelsolin (PBD1 and PBD2;
10–20 amino acids each) have been identified (38). The actin-
severing activity of gelsolin is located in the N-terminal half of
gelsolin (38). Thus, modulation of the actin cytoskeleton by
gelsolin is a regulated and complex process that involves both
the severing and capping properties of gelsolin.
Gelsolin was shown to be highly expressed in a variety of cell
types involved in active plasma membrane recycling, including
osteoclasts, kidney intercalated cells, and spermatozoa (39–
41). It was proposed that active remodeling of the actin cy-
toskeleton by gelsolin might regulate the endo/exocytic activity
in these cells. In this study, we show that gelsolin is highly
expressed in another cell type involved in active recycling, the
clear cells of the epididymis. Furthermore, osteoclasts, kidney
intercalated cells, and epididymal clear cells all express high
levels of the vacuolar H-ATPase (V-ATPase) on intracellular
vesicles and the plasma membrane (42–46). Active proton se-
cretion by these cells via the V-ATPase is responsible for bone
resorption (osteoclasts) (46, 47), systemic acid/base homeosta-
sis (intercalated cells) (48), and maintenance of sperm in a
dormant state during maturation and storage in the epididy-
mis (clear cells) (43).
The V-ATPase is a complex enzyme composed of numerous
subunits, some of which are present in multiple copies in each
holoenzyme (49, 50). It is ubiquitously expressed in eukaryotic
cells, where it is located in intracellular acidic organelles, in-
cluding lysosomes, the Golgi apparatus, secretory vesicles, and
endosomes. In some specialized cells such as osteoclasts, kid-
ney intercalated cells, and epididymal clear cells, the V-ATPase
is also expressed in the plasma membrane (46, 48, 51, 52). In
these cells, the V-ATPase rapidly recycles between intracellu-
lar vesicles and the plasma membrane, and an increase in
proton secretion correlates with an increase in V-ATPase sur-
face expression (48, 53–55).
We (59) and others (55–58) have shown that the V-ATPase
can bind either directly or indirectly to actin via two of its
subunits, B and C, located on the cytoplasmic side of the mem-
brane. The B subunit of the V-ATPase exists in two forms
known as B1 and B2. The B1 subunit is predominant in kidney
intercalated cells and epididymal clear cells (44, 45, 60),
whereas osteoclasts express the B2 isoform (47). These iso-
forms are highly homologous, and they both bind directly to
actin via their cytoplasmic N termini (56, 58). In addition, the
B1 subunit, but not the B2 subunit, contains a DTAL motif in
its C terminus, which allows for binding to the PDZ domain-
containing protein NHERF1 (59). NHERF1, which was origi-
nally identified as a cofactor for the regulation of the Na/H
exchanger NHE3 (61), binds to the ezrin/radixin/moesin family
of actin-binding proteins and links many membrane proteins to
the actin cytoskeleton (62). Thus, NHERF1 may allow for in-
direct interaction between V-ATPase and actin. It was pro-
posed that interaction between the V-ATPase and F-actin is
required for V-ATPase-dependent proton secretion by oste-
oclasts (55), but whether this is also the case in other cell types
remains to be elucidated. In addition, although the role of the
actin cytoskeleton in regulating clathrin-mediated endocytosis
is clearly emerging (20, 63), its role in the recycling of V-
ATPase, which utilizes unique clathrin- and caveolin-inde-
pendent mechanisms (51, 64), has not been demonstrated yet.
In this study, we used epididymal clear cells as a model
system to examine the role of actin cytoskeleton modulation via
gelsolin in regulating V-ATPase-dependent proton secretion.
This model allows the study of V-ATPase recycling in intact
cells while they reside in their native epithelium. The epidid-
ymis establishes a low luminal pH of 6.5–6.8 to maintain
spermatozoa in a quiescent state during their maturation and
storage in this organ. We have shown previously that clear cells
are key players in this acidification process (43). In addition, we
have shown that V-ATPase recycling in these cells is strongly
dependent on luminal pH and that a bicarbonate-regulated
soluble adenylyl cyclase-dependent rise in cAMP in response to
alkaline luminal pH induces an accumulation of V-ATPase in
the apical membrane, leading to significant elongation of V-
ATPase-containing microvilli (65). The resulting increase in
proton secretion by clear cells would re-establish the pH of the
lumen to its resting acidic value. We now show that polymeri-
zation of the actin cytoskeleton inhibits the alkaline pH-in-
duced V-ATPase apical cell-surface mobilization in gelsolin-
rich clear cells. In addition, a PIP2-binding peptide that
competes for the binding of PIP2 with gelsolin, thereby prevent-
ing uncapping of gelsolin from actin filament barbed ends,
favors the apical membrane accumulation of V-ATPase. We
also show that the phospholipase C (PLC) calcium signaling
pathway is involved in the regulation of V-ATPase trafficking.
These data point to a major role for the actin cytoskeleton-
remodeling protein gelsolin in regulating V-ATPase endocyto-
sis, a process that is broadly used by specialized acidifying
V-ATPase-expressing cells in various tissues and organs.
EXPERIMENTAL PROCEDURES
Tissue Fixation and Immunofluorescence—Adult male Sprague-
Dawley rats (Charles River Laboratories, Wilmington, MA) were anes-
thetized using an intraperitoneal sodium pentobarbital injection of 10
mg/100 g of body weight. They were then perfused through the left
ventricle of the heart with phosphate-buffered saline (PBS; 12 mM
phosphate buffer containing 137 mM NaCl and 2.7 mM KCl, pH 7.4),
followed by PLP fixative containing 10 mM sodium periodate, 75 mM
lysine, 4% paraformaldehyde, and 5% sucrose. Epididymides were har-
vested and further fixed overnight at 4 °C in PLP fixative. Tissues were
then washed in PBS and stored in PBS containing 0.02% sodium azide.
PLP-fixed epididymides were cryoprotected in a solution of 30%
sucrose in PBS, and 5-m cryostat sections were cut and picked up onto
Fisher Superfrost Plus microscope slides as described previously (42,
65). Sections were hydrated for 15 min in PBS and treated with 1%
SDS, an antigen retrieval technique that we have described previously
(66). Nonspecific binding of the antibody was blocked by preincubation
of sections with 1% bovine serum album in PBS containing 0.02%
sodium azide for 15 min. Sections were then incubated with the primary
antibody for 90 min at room temperature, followed by two washes of 5
min in high salt PBS (2.7% NaCl) to reduce nonspecific staining and one
wash in normal PBS. The secondary antibody was applied for 1 h at
room temperature and washed as described above. Double labeling was
performed by subsequent incubation of the sections with additional
primary and secondary antibodies.
The primary antibodies used were as follows. Affinity-purified
chicken or rabbit antibodies raised against the last 10 C-terminal
amino acids (C-GANANRKFLD) of the E subunit of the V-ATPase were
used at a 1:5 or 1:50 dilution, respectively, and have been characterized
previously (59, 65). A rabbit polyclonal antibody against gelsolin, kindly
provided and characterized previously by Dr. David J. Kwiatkowski
(39), was used at a 1:1200 dilution. A monoclonal antibody raised
1 The abbreviations used are: PIP2, phosphatidylinositol 4,5-bisphos-
phate; PBD, phosphoinositide-binding domain; V-ATPase, vacuolar H-
ATPase; PLC, phospholipase C; PBS, phosphate-buffered saline; HRP,
horseradish peroxidase; BAPTA-AM, 1,2-bis(2-aminophenoxy)ethane-
N,N,N,N-tetraacetic acid tetrakis(acetoxymethyl ester); CPT-cAMP,
8-(4-chlorophenylthio)-cAMP; sAC, soluble adenylyl cyclase.
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against chicken gizzard actin (Chemicon International, Inc., Temecula,
CA) was used at a 1:100 dilution. The secondary antibodies used were
donkey anti-chicken antibody coupled to fluorescein isothiocyanate (7.5
g/ml), goat anti-rabbit IgG coupled to Cy3 (2 g/ml) or fluorescein
isothiocyanate (7.5 g/ml), and goat anti-mouse IgG coupled to Cy3 (2
g/ml) and were purchased from Jackson ImmunoResearch Laborato-
ries, Inc. (West Grove, PA) . All antibodies were diluted in Dako anti-
body diluent. The slides were mounted in Vectashield (Vector Labora-
tories, Burlingame, CA) diluted 1:1 with 1.5 M Tris buffer, pH 8.5. Some
slides were mounted in Vectashield containing the DNA marker 4,6-
diamidino-2-phenylindole to stain the nucleus. Images were acquired
either with a Hamamatsu Orca charge-coupled device camera mounted
on a Nikon E800 epifluorescence microscope using IPLab Spectrum
software (Scanalytics, Inc., Fairfax, VA) or with a Zeiss Axioplan mi-
croscope equipped with a Radiance 2000 confocal laser scanning system
(Bio-Rad). Final images were imported into and printed from Adobe
Photoshop.
Western Blotting—Homogenate from total epididymis was resuspended
in Laemmli sample buffer (Bio-Rad) and boiled for 5 min in Laemmli
sample buffer containing 2.5% -mercaptoethanol. Electrophoresis was
performed using Tris/glycine/SDS running buffer (Boston BioProducts,
Inc., Worcester, MA) on 4–20% polyacrylamide gel (Cambrex Bio Science
Walkersville, Inc., Walkersville, MD). After transfer to Immun-Blot poly-
vinylidene difluoride membrane (Bio-Rad), an overnight incubation was
performed at 4 °C with anti-gelsolin antibody at a dilution of 1:10,000.
Horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (Pierce)
was then applied at a 1:10,000 dilution for 1 h at room temperature.
Proteins were detected using Western Lightning Western Blot Chemilu-
minescence Reagent Plus (PerkinElmer Life Sciences).
Detection of Proton Secretion Using a Self-referencing Proton-selec-
tive Electrode—The effect of actin polymerization by jasplakinolide on
proton secretion from intact vas deferens was measured using an ex-
tracellular proton-selective electrode as we have described previously
(42, 43, 67). The proximal vas deferens was dissected, cut open to expose
the apical surface of the epithelium, and bathed in a PBS solution of low
buffering capacity (2 mM phosphate). No bath perfusion was performed
to allow a proton gradient to build up near the apical surface of V-
ATPase-rich cells. The proton-selective electrode was positioned near
the surface of the tissue, and oscillations of the electrode were per-
formed perpendicularly to the apical membrane with an amplitude of 50
m and a frequency of 0.3 Hz. The difference in proton equilibrium
potentials, measured at the extreme points of oscillation, is proportional
to the proton flux generated by the vas deferens. The Nernstian slope of
the electrode was determined before and after each experiment using
calibration solutions adjusted to pH 6.0, 7.0, and 8.0. The effect of
jasplakinolide was examined on seven vas deferens. A Student’s t test
for paired experiments was performed, and differences were considered
significant at p  0.05. The effect of the vehicle (methanol) was also
assessed in a separate group of three vas deferens.
In Vivo Perfusion of the Distal Cauda Epididymidis: V-ATPase Lo-
calization and Detection of Endocytosis—Rats were anesthetized as
described above. The vas deferens and epididymis were exposed, and
the vas deferens was perfused through the lumen using a microcannula
(0.4-mm outer diameter, 0.2-mm inner diameter; Kent Scientific,
Torrington, CT) as described previously (65). A small incision was made
in the distal portion of the cauda epididymidis to allow the perfusate to
flow out of the tubule. The vas deferens and distal cauda epididymidis
were retrograde-perfused at a rate of 45 l/min using a syringe pump
(Model 100, KD Scientific Inc., Holliston, MA). The lumen was initially
washed free of sperm in PBS adjusted to either pH 6.5 or 7.8 (control
conditions) as indicated. To detect endocytosis, HRP (Sigma) was added
to PBS at a concentration of 5 mg/ml for 15 min. The lumen was then
flushed for 3 min with ice-cold PBS adjusted to the appropriate pH to
remove non-endocytosed HRP. The vas deferens and cauda epididymi-
dis were harvested and fixed by immersion either for 4 h at room
temperature or overnight at 4 °C in PLP fixative. Tissues were washed
in PBS and stored in PBS containing 0.02% azide at 4 °C until further
utilization.
Some epididymides were subjected to different experimental condi-
tions as described in detail under “Results.” To induce actin filament
polymerization, 10 M jasplakinolide (Molecular Probes, Inc., Eugene,
Oregon), which binds to F-actin and prevents its depolymerization, was
added to the luminal perfusate. To inhibit actin filament assembly, we
used a 10-residue peptide derived from the PBD2 PIP2-binding region of
gelsolin (PBP10, 20 M), provided by Dr. John H. Hartwig (68). This
peptide was made membrane-permeable by coupling to rhodamine B
and was shown to potentially bind to PIP2. By competing with gelsolin
for binding PIP2, it prevents the uncapping of gelsolin from F-actin and
the gelsolin-dependent desequestering of actin monomers, which are
both required for actin assembly (68). Thus, the net effect induced by
the PBP10 peptide is depolymerization of the actin cytoskeleton. In
addition, to reduce the intracellular calcium concentration, BAPTA-AM
(5 M; Sigma) was added to the luminal perfusate in the absence or
presence of the permeant cAMP analog 8-(4-chlorophenylthio)-cAMP
(CPT-cAMP; 1 mM; Sigma). Finally, the inhibitor U-73122 (10 M;
Sigma) was used to inhibit PLC.
V-ATPase and HRP internalization was detected by immunofluores-
cence (65). 5-m cryostat sections were processed as described above,
but an additional permeabilization procedure with 0.1% Triton X-100
was included between the hydration and blocking steps to detect HRP
in endosomes. After incubation with chicken anti-V-ATPase antibody
and then donkey anti-chicken IgG coupled to fluorescein isothiocyanate,
the sections were incubated with anti-HRP polyclonal antibody (Jack-
son ImmunoResearch Laboratories, Inc.) at a 1:5000 dilution, followed
by Cy3-conjugated goat anti-rabbit IgG.
Quantification of V-ATPase Apical Membrane Accumulation—The
level of accumulation of V-ATPase in microvilli was quantified by meas-
uring the area occupied by V-ATPase-labeled microvilli as we have
described previously (65). Confocal images were imported into IPLab
software as TIFF files, and the segmentation procedure was used to
measure the area of V-ATPase-positive microvilli. This value was nor-
malized for the width of the cell at the apical pole. At least three
epididymides from different animals were perfused for each condition,
and a minimum of 10 cells/tissues were examined for a total of at least
30 cells/condition. Analysis of variance and Student’s t test were per-
formed. Differences were considered significant at p  0.05.
Confirmation of Actin Polymerization by Jasplakinolide—Rats were
anesthetized, and vas deferens were harvested, cut open, and washed
free of sperm. The epithelium was peeled off the surrounding connective
and muscle tissues as we have described previously (69) and incubated
either with 10 M jasplakinolide in PBS or with the vehicle alone
(PBS/methanol) for 45 min at room temperature. Triton X-100-soluble
and -insoluble fractions were prepared based on a previous publication
(70). The epithelia from both control and jasplakinolide-treated vas
deferens were freeze-thawed three times in 100 l of PBS containing
protease inhibitors (Complete mini, Roche Diagnostics) and then cen-
trifuged at 16,000  g for 17 min. The supernatant was kept and
designated as the soluble fraction. The pellet was homogenized with
100 l of PBS containing 1% Triton X-100 and protease inhibitors. This
fraction was designated as the insoluble fraction.
Equal volumes of each fraction were subjected to electrophoresis to
assess the level of polymerized insoluble actin and monomeric soluble
actin. Fractions were resuspended in Laemmli sample buffer and boiled
for 5 min in Laemmli sample buffer containing 2.5% -mercaptoetha-
nol. Electrophoresis was performed as described above. Western blot-
ting was performed using monoclonal antibody raised against chicken
gizzard actin (1:2000 dilution), followed by HRP-conjugated goat anti-
mouse IgG (1:10,000 dilution; Pierce).
Effect of Jasplakinolide on V-ATPase Expression—The vas deferens
and distal cauda epididymidis were perfused in vivo as described above
with PBS containing either 10 M jasplakinolide or the vehicle alone
(methanol). After a 45-min perfusion period, the vas deferens and cauda
epididymidis were harvested and immediately frozen in liquid nitrogen
for protein extraction. 20 g of proteins were subjected to electrophore-
sis as described above. Western blotting using the affinity-purified
anti-chicken anti-V-ATPase antibody at a dilution of 1:500 was per-
formed as described above. As a loading control, the same membranes
were blotted with -tubulin monoclonal antibody (1:20,000 dilution;
Chemicon International, Inc.).
RESULTS
High Expression of Gelsolin in Clear Cells of the
Epididymis
Gelsolin was localized by immunofluorescence in cryostat
sections of PLP-fixed epididymis. High levels of gelsolin were
detected in clear cells (Fig. 1A, red), identified by their V-
ATPase expression (yellow). In contrast, adjacent principal
cells were negative for gelsolin. Higher magnification images
show that whereas gelsolin was present throughout the cyto-
plasm of clear cells, it was very abundant in their apical mi-
crovilli (Fig. 1B, green). Double labeling revealed very strong
actin staining in the stereocilia of principal cells, but little or no
detectable actin in clear cell microvilli (Fig. 1B, red), indicating
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that the actin cytoskeleton is much less organized in the apical
pole of clear cells compared with principal cells. We postulated
that the low level of actin polymerization in clear cells is at-
tributed to their very high gelsolin content. A strong band at
90 kDa corresponding to gelsolin (71) was detected by West-
ern blotting (Fig. 1C).
Effect of Jasplakinolide on Net Proton Secretion
To evaluate the functional role of gelsolin in modulating
V-ATPase-dependent proton secretion, we first used the potent
actin polymerizing agent jasplakinolide to overcome its action.
The effect of jasplakinolide on net proton secretion was exam-
ined in cut-open vas deferens using an extracellular proton-
selective electrode. As shown in Fig. 2A (upper trace) and as we
have described previously (42, 43, 67), stable proton secretion
was detected under control conditions. Addition of the vehicle
(methanol) to the control solution induced a transient disturb-
ance of the proton gradient, which rapidly recovered to the
control value. Bafilomycin A1 (1 M) or concanamycin A (1 M)
induced a rapid decrease in proton secretion, indicating the
participation of the V-ATPase. Addition of 10 M jasplakinolide
(Fig. 2A, lower trace) induced a progressive inhibition of proton
secretion compared with the control. At the end of the experi-
mental period, addition of bafilomycin A1 or concanamycin A
had either no or little effect on net proton secretion, indicating
a significant reduction in V-ATPase-dependent proton flux by
jasplakinolide. Fig. 2B shows a histogram of the mean values
obtained from a series of seven vas deferens. For each vas
deferens, both the control value (measured prior to addition of
jasplakinolide) and the jasplakinolide value (measured 40 min
after its addition) were corrected for the residual value meas-
ured after addition of bafilomycin and/or concanamycin to de-
termine the effect of jasplakinolide on V-ATPase-dependent
proton secretion. A Student’s t test for paired experiments
revealed a significant reduction in V-ATPase-dependent proton
secretion by jasplakinolide.
Effect of Jasplakinolide on V-ATPase Localization
The effect of jasplakinolide on the localization of V-ATPase
and level of endocytosis in clear cells was then examined. In
these cells, an increase in V-ATPase surface expression and in
apical surface area (including microvilli) closely correlates with
an increase in proton secretion. We have shown previously that
the V-ATPase relocalizes from intracellular subapical vesicles
to the apical microvilli of clear cells in response to an elevation
in luminal pH (65). This increase in cell-surface expression of
the V-ATPase leads to an increase in the number and length of
V-ATPase-labeled microvilli. Here, we tested the effect of jas-
plakinolide on this alkaline pH-induced response. Epididymi-
des were perfused for 10 min with PBS adjusted to either pH
6.5 or 7.8 and containing 10 M jasplakinolide or the vehicle
alone (methanol). HRP was then added, still in the presence of
jasplakinolide or methanol, for an additional period of 15 min.
Non-internalized HRP was washed in ice-cold PBS (with or
without jasplakinolide) at the appropriate pH for 3 min prior to
fixation of the tissue with PLP fixative. As we have described
previously (65), under control conditions, clear cells possessed a
much higher endocytic activity compared with adjacent princi-
pal cells at both acidic and alkaline luminal pH (Fig. 3, A and
B). Under control conditions (methanol) at a luminal pH of 6.5,
the V-ATPase was distributed between apical microvilli and
intracellular subapical vesicles (Fig. 3A). In these cells, V-
ATPase-containing vesicles partially co-localized with HRP-
containing endosomes (yellow), indicating that a significant
amount of V-ATPase was located in the endocytic compart-
ment. At an alkaline pH of 7.8, the V-ATPase was located
mainly in well developed apical microvilli and was not present
in most HRP-positive endosomes, indicating accumulation of
V-ATPase in the apical membrane of clear cells (Fig. 3B). In
contrast, after perfusion in the presence of jasplakinolide at
pH 7.8, a complete internalization of V-ATPase was observed,
despite the alkaline pH (Fig. 3C), leading to the retraction of
apical microvilli. Thus, jasplakinolide completely inhibited
the alkaline pH-induced V-ATPase apical translocation. A
similar V-ATPase internalization was also observed by jas-
plakinolide at pH 6.5 (data not shown). In addition, no HRP-
containing endosomes, either stained or unstained for V-
ATPase, were observed under these conditions, indicating
that both V-ATPase-related endocytosis and V-ATPase-unre-
lated endocytosis were inhibited following preincubation with
jasplakinolide.
The level of V-ATPase internalization induced by jasplakino-
lide at alkaline pH was quantified. The intensity of V-ATPase
staining in the apical pole of clear cells was measured after
FIG. 1. Gelsolin localization in the epididymis. A, double immunofluorescence staining showing gelsolin (red) and V-ATPase (yellow) in rat
cauda epididymidis. Strong gelsolin staining was observed in clear cells, identified by their positive immunoreactivity for V-ATPase. Adjacent
principal cells were negative for gelsolin. B, higher magnification showing gelsolin (green) and actin (red). Nuclei were stained blue by
4,6-diamidino-2-phenylindole. Although very strong actin staining was detected in the stereocilia of principal cells, no detectable actin was
observed in the apical microvilli of clear cells. In these cells, gelsolin was detected throughout the cytoplasm as well as in the apical microvilli. C,
detection of gelsolin by Western blotting in total homogenates from rat epididymis. 20 g of protein were loaded onto the gel. A strong band at 90
kDa was detected, indicating high levels of gelsolin in the epididymis (arrow). Bars  25 m (A) and 10 m (B).
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jasplakinolide treatment using IPLab Spectrum densitometric
software. Cryostat sections of control and jasplakinolide-
treated epididymides were stained simultaneously for the V-
ATPase, and digital images were acquired with identical cam-
era parameters. Lower magnification images were taken to
increase the number of cells examined (Fig. 4). Under control
conditions, bright V-ATPase staining was observed in the api-
cal pole of clear cells (Fig. 4A, arrows), whereas in the presence
of jasplakinolide, V-ATPase apical staining was significantly
reduced (Fig. 4B, arrows). The mean pixel intensity of the
V-ATPase-associated staining in the apical pole of clear cells
was quantified using the IPLab Spectrum segmentation proce-
dure as we have described previously (72). A total of 713 and
495 cells were examined from three epididymides exposed to
control and jasplakinolide conditions, respectively. As shown in
Fig. 4C, a significant reduction in V-ATPase apical staining
was observed after jasplakinolide treatment. These data sug-
gested either a reduction in V-ATPase expression or redistri-
bution of the V-ATPase throughout the cell following jas-
plakinolide exposure. Similar levels of V-ATPase protein were
detected by Western blotting in epididymides exposed to con-
trol and jasplakinolide conditions (Fig. 4D, upper panel), indi-
cating that jasplakinolide did not affect the expression of V-
ATPase. -Tubulin was used as a loading control in all samples
tested (Fig. 4D, lower panel). Thus, the reduction in V-ATPase
apical immunostaining detected in the presence of jasplakino-
lide is consistent with a reduction in the amount of V-ATPase
present in apical microvilli and its redistribution in intracellu-
lar vesicles scattered within deeper intracellular regions.
Actin Polymerization by Jasplakinolide
The level of actin polymerization induced by jasplakinolide
was tested in epithelial sheets isolated from cut-open vas def-
erens, a preparation that we have described previously (69).
After incubation either in PBS, pH 7.4, or in PBS containing 10
M jasplakinolide for 45 min, Triton X-100-soluble and -insol-
FIG. 2. Effect of jasplakinolide on proton secretion. A, representative traces showing net proton secretion in cut-open proximal vas deferens
under control conditions (upper trace) and upon jasplakinolide addition (lower trace). Apical proton flux was detected using an extracellular
self-referencing proton-selective electrode. Upper trace, at time 0, addition of the vehicle (methanol; arrow) induced a rapid increase in the signal
due to transient disturbance of the proton gradient. The signal then rapidly recovered to the control value as the proton gradient was re-established
and remained stable for periods of up to 1 h. A marked inhibition of net proton secretion was observed when bafilomycin A1 or concanamycin A
was added at the end of the experimental period, indicating the participation of V-ATPase in this process. Concanamycin A had no further effect
after inhibition by bafilomycin. Lower trace, jasplakinolide induced a progressive inhibition of proton secretion to a level that was not further
inhibited by bafilomycin A1 or concanamycin A. B, histogram showing the mean effect of jasplakinolide (Jas) on bafilomycin-sensitive proton
secretion (mean  S.E., n  7) measured 40 min after addition of jasplakinolide. The control value was measured in the same vas deferens prior
to addition of jasplakinolide. Both control and jasplakinolide values were corrected for the residual value measured after bafilomycin A1 addition.
*, p  0.001.
FIG. 3. Effect of jasplakinolide on pH-induced V-ATPase apical accumulation. Confocal images showing clear cells from cauda
epididymides perfused at a luminal pH of 6.5 (A) or 7.8 (B) or in the presence of jasplakinolide at pH 7.8 (C). Double immunofluorescence labeling
for V-ATPase (green) and internalized HRP (red) was performed. A, at a luminal pH of 6.5, a high apical endocytic activity was observed in clear
cells compared with principal cells (yellow and red). In clear cells, V-ATPase was distributed between subapical vesicles and short apical microvilli.
The yellow staining indicates partial co-localization of HRP-containing endosomes with V-ATPase-containing vesicles. B, at a luminal pH of 7.8,
a higher apical endocytic activity was also seen in clear cells compared with principal cells, but V-ATPase was located mainly in apical microvilli
(green) and not in HRP-containing endosomes (red). Longer and more numerous microvilli were detected at pH 7.8 compared with pH 6.5. C,
perfusion with jasplakinolide for a total period of 25 min induced a complete internalization of V-ATPase, despite an alkaline pH of 7.8. A complete
retraction of apical microvilli was observed, and no HRP-containing endosomes were detected. The arrows indicate the frontier between apical
microvilli and the subapical region of clear cells. In C, no microvilli were detected. Bars  10 m.
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uble fractions were isolated, and the level of actin was assessed
in each fraction by Western blotting. Jasplakinolide induced a
marked increase in the amount of insoluble F-actin and a
decrease in soluble monomeric actin (G-actin) compared with
the control (Fig. 5A). Quantification analysis revealed a sub-
stantial increase in the ratio between F-actin and G-actin after
jasplakinolide treatment compared with the ratio measured
under control conditions (Fig. 5B), confirming the expected
actin polymerization by jasplakinolide. Similar results were
obtained in three different experiments.
Effect of Jasplakinolide on cAMP-induced Apical
Accumulation of V-ATPase
We have shown previously that cAMP induces the accumu-
lation of V-ATPase in apical microvilli, even at acidic luminal
pH (65). We tested whether this process is affected by jas-
plakinolide. Epididymides were perfused for 10 min with jas-
plakinolide, followed by a 15-min perfusion with the permeant
cAMP analog CPT-cAMP (1 mM), still in the presence of jas-
plakinolide. We first examined the localization of V-ATPase
after the first 10 min of jasplakinolide exposure. As shown in
Fig. 6A, V-ATPase was located mainly in apical vesicles, and
very few short V-ATPase-labeled microvilli were detected un-
der these conditions, indicating that the majority of V-ATPase
internalization took place during the first 10 min of jasplakino-
lide exposure. Addition of CPT-cAMP after this preincubation
period for a period of 15 min did not cause significant apical
accumulation of V-ATPase (Fig. 6B), and almost no V-ATPase-
labeled microvilli were detected. Control epididymides were
perfused for a period of 15 min with CPT-cAMP without jas-
plakinolide. Consistent with our previously published data
(65), V-ATPase was present mostly in well developed apical
microvilli (Fig. 6C), indicating apical redistribution of
V-ATPase by cAMP. These results indicate that jasplakinolide
inhibited the cAMP-induced V-ATPase accumulation in apical
microvilli.
We postulated that the maintenance of a depolymerized ac-
tin cytoskeleton, possibly via gelsolin activity, is essential for
the recycling of V-ATPase. To test this hypothesis, a PIP2-
binding peptide (PBP10) that corresponds to the PDB2 PIP2-
FIG. 4. Quantification of the effect of jasplakinolide on V-ATPase localization. Immunofluorescence staining for V-ATPase was
performed on cauda epididymides perfused in the absence (A) and presence (B) of jasplakinolide, and digital images were captured using identical
acquisition parameters. A: in the absence of jasplakinolide, bright V-ATPase staining was observed in the apical pole of clear cells (arrows). B:
weaker V-ATPase apical staining was detected after jasplakinolide treatment (arrows). C: the mean pixel intensity of V-ATPase-associated labeling
in the apical pole of clear cells was measured using IPLab Spectrum software. A significant decrease in the intensity of V-ATPase staining was
observed after jasplakinolide treatment (JAS; n  495 cells) compared with the control (CTL; n  713 cells). *, p  0.005. D: upper panel, shown
are the results fromWestern blot analysis of V-ATPase expression in three different epididymides perfused in vivowith PBS (control (CTL)) or with
PBS containing jasplakinolide (JAS). 20 g of total proteins were loaded onto each lane. Western blotting using an antibody against the E subunit
(31 kDa) of the V-ATPase revealed similar band intensity in all samples, indicating that jasplakinolide did not affect the total amount of V-ATPase.
Lower panel: shown are the loading controls using anti--tubulin antibody. Similar levels were observed, indicating that the same amount of
material was loaded onto each lane.
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binding region of gelsolin (68) was used. This peptide prevents
the binding of PIP2 to gelsolin.
Effect of the PIP2-binding Peptide PBP10 on
V-ATPase Recycling
As mentioned above, PIP2 binds to gelsolin and dissociates it
from the barbed ends of actin filaments, thus promoting actin
polymerization. By preventing the binding of PIP2 to gelsolin,
the PBP10 peptide favors the establishment of a depolymerized
actin cytoskeleton (68). The effect of PBP10 on the distribution
of V-ATPase in epididymides perfused at either acidic or alka-
line luminal pH was tested. The epididymides were first per-
fused with PBS with or without PBP10 (20 M) for 10 min.
Horseradish peroxidase was then added for an additional pe-
riod of 15 min, and washes were performed as described above.
In the presence of PBP10 at a luminal pH of 6.5, the V-ATPase
was located mainly in apical microvilli, and very little or no
co-localization with HRP-containing endosomes was detected
(Fig. 7A), a situation that resembled the V-ATPase localization
observed under control conditions at alkaline pH (compare with
Fig. 3B). Thus, PBP10 induced the apical accumulation of
V-ATPase, despite the acidic luminal pH. At a luminal pH of
7.8, the usual microvillus localization of V-ATPase was ob-
served in the presence of the peptide (Fig. 7B). The level of
insertion of V-ATPase into microvilli was quantified using
IPLab Spectrum software as we have described previously (65).
We have shown, by immunoelectron microscopy, that the apical
microvillus extension observed at alkaline pH is accompanied
by an increase in the number of V-ATPase molecules associated
with the plasma membrane, indicating that accumulation of
V-ATPase in the membrane occurs in parallel with the devel-
opment of apical microvilli (65). Thus, the area occupied by
V-ATPase-labeled microvilli was measured and normalized for
the width of the cells at the apical pole for each cell and was
used as an indicator of the level of V-ATPase accumulation in
apical microvilli as we have described previously (65). As
shown in Fig. 8, the surface occupied by the apical microvilli
was significantly increased in the presence of PBP10 at a
luminal pH of 6.5 (PBP10 6.5) compared with the control (CTL
6.5) and was not different from that measured under control
conditions at a luminal pH of 7.8 (CTL 7.8). No additional effect
of the peptide was observed at pH 7.8 (PBP10 7.8) compared
with the control (CTL 7.8). These results indicate that the
PBP10 peptide induced the apical accumulation of V-ATPase at
acidic luminal pH, but had no significant effect on V-ATPase
localization at alkaline pH.
Role of Calcium in Regulating V-ATPase Recycling
In addition to its role in modulating the actin cytoskeleton,
gelsolin has also been proposed to participate in intracellular
calcium signaling by controlling the availability of PIP2 sub-
strates (73). Inhibition of PLC following competition with gel-
solin for PIP2 was shown both in vivo and in vitro (73, 74). As
calcium is actively involved in the regulation of vesicle recy-
cling and in modulating V-ATPase-dependent proton secretion
in some acidifying cells (75, 76), we examined whether the
effects observed with the PBP10 peptide might be attributed to
alteration of the calcium signaling pathway.
Effect of BAPTA-AM on pH-regulated V-ATPase Recycling—
First, the effect of the calcium chelator BAPTA-AM on V-
FIG. 5. Actin polymerization by jasplakinolide. A, shown are the results from Western blot analysis of the amount of actin present in the
Triton X-100-soluble (S) and -insoluble (I) fractions of epithelial cell sheets isolated from proximal vas deferens incubated with PBS (control (CTL))
or jasplakinolide (JAS) for 45 min. Both soluble and insoluble fractions were solubilized in SDS-containing sample buffer, and an equal volume of
each fraction was loaded onto the gel. Western blotting using anti-actin antibody revealed that the amount of soluble monomeric G-actin was
markedly reduced and that the amount of insoluble F-actin was increased after jasplakinolide treatment. B, semiquantitative analysis of the
intensity of the bands revealed, as expected, that jasplakinolide induced a marked increase in the ratio of insoluble to soluble fractions compared
with the control, indicating significant polymerization of the actin cytoskeleton.
FIG. 6. Effect of jasplakinolide on cAMP-induced V-ATPase apical accumulation. The confocal images show clear cells from cauda
epididymides perfused with PBS containing jasplakinolide for 10 min (A); with PBS containing jasplakinolide for 10 min, followed by CPT-cAMP,
still in the presence of jasplakinolide for 15 min (B); or with PBS containing CPT-cAMP for 15 min (C). A, V-ATPase was present in apical vesicles,
and no apical microvilli were detected, indicating significant V-ATPase internalization. B, no apical microvilli were detected, and V-ATPase was
located mainly in subapical vesicles, despite the presence of CPT-cAMP, indicating that preincubation with jasplakinolide abolished the
cAMP-induced V-ATPase apical translocation. C, the majority of V-ATPase was located in well developed apical microvilli, indicating that cAMP
induced the usual apical translocation of the pump. V-ATPase-labeled subapical vesicles were also detected. The arrows indicate the frontier
between the apical cytoplasm and the base of the apical microvilli. In A and B, no apical microvilli were detected. Bars  5 m.
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ATPase recycling was examined at acidic and alkaline luminal
pH. Epididymides were perfused with PBS, pH 6.5 or 7.8,
containing 5 M BAPTA-AM for 10 min, followed by PBS con-
taining HRP and BAPTA-AM for 15 min. Washes were per-
formed in the presence of BAPTA-AM. At pH 6.5, BAPTA-AM
increased the level of both V-ATPase-related (Fig. 7C, yellow)
and V-ATPase-unrelated (red) endocytosis. At pH 7.8,
BAPTA-AM prevented the accumulation of V-ATPase in apical
microvilli (Fig. 7D) and induced some degree of V-ATPase
internalization (yellow). Quantification analysis confirmed that
chelation of calcium with BAPTA induced a marked decrease in
the surface occupied by V-ATPase-positive microvilli at pH 7.8
(Fig. 8, BAPTA 7.8) compared with the control (CTL 7.8). No
effect of BAPTA-AM was detected at pH 6.5 (Fig. 8, BAPTA 6.5
versus CTL 6.5).
Effect of BAPTA-AM on cAMP-induced Apical Accumulation
of V-ATPase—We have shown previously that apical mem-
brane accumulation of the V-ATPase is triggered by a soluble
adenylyl cyclase (sAC)-dependent elevation in cAMP in re-
sponse to alkaline luminal pH (65). As sAC is regulated by
calcium (77), we tested whether the inhibition of the alkaline
pH-induced V-ATPase accumulation that we observed in the
presence of BAPTA-AM might have been secondary to reduced
activity of this enzyme. The effect of the permeant cAMP ana-
log CPT-cAMP was measured in the presence of BAPTA-AM
(Fig. 7F). Epididymides were perfused at a luminal pH of 6.5
with PBS containing BAPTA-AM (5 M) for 10 min, followed by
PBS containing BAPTA-AM, HRP, and 1 mM CPT-cAMP for 15
min. Washes were performed with cold PBS containing
BAPTA-AM and cAMP. The same protocol was repeated in the
absence of BAPTA-AM. Consistent with our previous study
(65), in the absence of BAPTA-AM, very well developed V-
ATPase-positive apical microvilli were detected with CPT-
cAMP (Fig. 7E). This result is similar to that shown in Fig. 6C.
Quantification analysis revealed that CPT-cAMP induced a
significant increase in the area occupied by V-ATPase-positive
microvilli compared with the control pH 6.5 group (Fig. 8, CTL
6.5  cAMP versus CTL 6.5), indicating apical membrane ac-
cumulation of the V-ATPase, despite the acidic luminal pH. In
contrast, shorter V-ATPase-positive microvilli were observed
when CPT-cAMP was added after preincubation with
BAPTA-AM (Fig. 7F) compared with the control CPT-cAMP
group (Fig. 7E). Quantification analysis revealed a significant
inhibition of the cAMP-induced V-ATPase apical accumulation
by BAPTA-AM (Fig. 8, BAPTA 6.5  cAMP versus CTL 6.5 
cAMP). This result indicates that intracellular calcium is a key
player in the cAMP-induced response and that the effects of
BAPTA-AM occurred downstream of sAC activity.
Role of PLC in pH-regulated V-ATPase Recycling—Finally,
we tested whether the PIP2-dependent PLC pathway is in-
volved in V-ATPase recycling. Epididymides were perfused at
pH 6.5 and 7.8 with the PLC inhibitor U-73122 (10 M) or with
the vehicle alone (Me2SO) for 30 min prior to adding HRP for 15
min, still in the presence of U-73122 or Me2SO alone. The
epididymides were then processed as described above. Whereas
no effect of U-73122 was observed at pH 6.5 (Fig. 9, A and C,
U-73122 6.5) compared with the control (Fig. 9C, CTL 6.5), a
significant reduction in the area occupied by V-ATPase-positive
apical microvilli was observed at pH 7.8 (Fig. 9, B and C,
U-73122 7.8) compared with the control (Fig. 9C, CTL 7.8).
These results indicate that the alkaline pH-induced apical
insertion of the V-ATPase depends on the PLC-dependent cal-
cium signaling pathway. They also show that the stimulatory
effects induced by the PBP10 peptide were not due to impair-
ment of the PIP2-dependent PLC pathway since inhibition of
PLC resulted in the opposite effect.
DISCUSSION
This study shows that clear cells of the epididymis express
very high levels of gelsolin, a common feature of other spe-
cialized V-ATPase-expressing proton-secreting cells: kidney
intercalated cells and osteoclasts. We examined whether
modulation of the actin cytoskeleton via gelsolin might play a
role in regulating V-ATPase recycling. We have shown pre-
viously that V-ATPase accumulates in the apical microvilli of
clear cells in response to an elevation in luminal pH (65), a
process that would increase proton secretion and re-establish
the resting acidic luminal pH of the epididymis, which is
FIG. 7. Role of gelsolin and calcium in pH- and cAMP-depend-
ent V-ATPase recycling. The confocal images show clear cells ex-
posed to different luminal conditions and double-stained for V-ATPase
(green) and HRP (red). A and B, perfusion with PBS containing PBP10
(a peptide that corresponds to the PBD2 PIP2-binding site of gelsolin) at
pH 6.5 and 7.8, respectively. A, at pH 6.5, V-ATPase was located mainly
in well developed apical microvilli. No yellow staining was visible,
indicating the absence of co-localization with HRP-containing endo-
somes. This result indicates that PBP10 induced V-ATPase apical ac-
cumulation, despite the acidic luminal pH. B, at pH 7.8, V-ATPase was
also located mainly in apical microvilli, and little or no co-localization
was observed in HRP-labeled endosomes. C and D, PBS containing
BAPTA-AM at pH 6.5 and 7.8, respectively. C, at pH 6.5, high levels of
V-ATPase-related (yellow) and V-ATPase-unrelated (red) endocytosis
were observed. The apical microvillus number and length were similar
to those seen under control conditions at this pH (compare with Fig.
3A). D, at pH 7.8, V-ATPase was distributed between apical microvilli
and HRP-containing endosomes (yellow). The apical microvilli were less
numerous and shorter compared with the controls at this pH (compare
with Fig. 3B). E and F, PBS containing CPT-cAMP at pH 6.5 in the
absence and presence of BAPTA-AM, respectively. E, CPT-cAMP in-
duced the accumulation of V-ATPase in well developed microvilli. This
result is similar to that shown in Fig. 6C. F, Shorter V-ATPase-labeled
microvilli were seen when CPT-cAMP was added in the presence of
BAPTA-AM. The arrows point to the frontier between apical microvilli
and the subapical region of the cells. Bars  5 m.
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necessary for sperm maturation and storage. A concomitant
significant increase in the number and length of apical mi-
crovilli, which contained a higher number of V-ATPase mol-
ecules/unit length of membrane, was observed under these
conditions. At acidic luminal pH, the V-ATPase constitutively
recycles, and a major portion of the pump is present in
HRP-labeled endosomes. Both the alkaline pH-induced mem-
brane accumulation and acidic pH-dependent internalization
of the V-ATPase occur rapidly, within 15 min. An elevation in
cAMP via sAC participates in the pH-induced V-ATPase ap-
ical accumulation (65). Thus, alkalinization of luminal pH,
followed by an increase in intracellular pH in clear cells,
leads to 1) elevation of the intracellular bicarbonate concen-
tration, 2) activation of sAC by bicarbonate, 3) elevation of
cAMP, and 4) accumulation of V-ATPase in apical microvilli
(65).
In this study, we hypothesized that the high level of gelsolin
in clear cells would favor V-ATPase apical accumulation, in
response to luminal pH elevation and/or cAMP increase, by
maintaining the actin cytoskeleton in a depolymerized state. To
test this hypothesis, we used the potent polymerizing agent
jasplakinolide to overcome the action of gelsolin. The complete
inhibition of alkaline pH- or cAMP-induced V-ATPase apical
accumulation by jasplakinolide indicates that dynamic remod-
eling of the actin cytoskeleton is required for these processes to
occur. In addition, a permeant peptide (PBP10) that mimics the
PBD2 PIP2-binding site of gelsolin (68) induced a significant
accumulation of V-ATPase in apical microvilli at acidic luminal
pH. PBP10 blocks actin assembly by preventing the uncapping
of gelsolin from the growing ends of the actin filaments and
induces major disruption of the actin cytoskeleton (68). A re-
cent study has shown that, in osteoclasts, peptides containing
the phosphoinositide-binding domains of gelsolin inhibit the
dissociation of endogenous gelsolin from actin filaments (41).
This results in loss of the actin ring located at the periphery of
the cells and prevents osteopontin-induced actin polymeriza-
FIG. 8. Quantification of V-ATPase accumulation in apical microvilli. The level of V-ATPase accumulation in microvilli was quantified
by measuring the area occupied by V-ATPase-labeled microvilli, normalized for the width of the cells at the apical pole for each cell. Control groups
were epididymides perfused with PBS containing the vehicle (Me2SO) for 10 min, followed by HRP for 15 min in PBS containing Me2SO at a
luminal pH of 6.5 or 7.8. Under control conditions, the area occupied by V-ATPase-positive microvilli was significantly higher at a luminal pH of
7.8 (CTL 7.8) compared with a luminal pH of 6.5 (CTL 6.5). The PBP10 peptide induced a significant increase at pH 6.5 (PBP10 6.5) compared with
the control (CTL 6.5). No effect was induced by PBP10 at pH 7.8 (PBP10 7.8) compared with the control (CTL 7.8). BAPTA-AM prevented the
increase in the area occupied by V-ATPase-positive microvilli induced at pH 7.8 (BAPTA 7.8 versus CTL 7.8), but had no effect on the microvillus
area observed at pH 6.5 (BAPTA 6.5 versus CTL 6.5). In the absence of BAPTA-AM, CPT-cAMP induced a significant increase in the area occupied
by V-ATPase microvilli, despite the acidic pH of 6.5 (CTL 6.5  cAMP versus CTL 6.5). In contrast, BAPTA-AM markedly decreased the response
induced by CPT-cAMP (BAPTA 6.5  cAMP versus CTL 6.5  cAMP). *, p  0.05 versus CTL 6.5; **, p  0.05 versus CTL 7.8; ***, p  0.05 versus
CTL 6.5  cAMP.
FIG. 9. Effect of the PLC inhibitor U-73122 on pH-regulated V-ATPase recycling. Cauda epididymides were perfused with PBS adjusted
to pH 6.5 (A) or 7.8 (B) and containing U-73122 for 30 min, followed by a 15-min perfusion with HRP, still in the presence of U-73122. Controls
were carried out with a pre-perfusion period of 30 min with PBS containing the vehicle (Me2SO) at both pH values, followed by 15 min with PBS
containing HRP and Me2SO. Double immunofluorescence labeling for V-ATPase (green) and HRP (red) was performed. A, at pH 6.5 in the presence
of U-73122, V-ATPase was distributed between short apical microvilli and subapical HRP-containing vesicles, as for the control at pH 6.5 (compare
with Fig. 3A). B, at pH 7.8, U-73122 prevented the elongation of microvilli that was usually seen under control conditions (compare with Fig. 3B),
and V-ATPase was distributed between intracellular endosomes and short apical microvilli. C, quantification of the area occupied by V-ATPase-
labeled microvilli confirmed that inhibition of PLC by U-73122 prevented the alkaline-pH induced accumulation of V-ATPase in apical microvilli
(U-73122 7.8 versus CTL 7.8). Identical microvillus area values were measured in the presence or absence of U-73122 at pH 6.5 (U-73122 6.5 versus
CTL 6.5). *, p  0.05 versus CTL 6.5; **, p  0.05 versus CTL 7.8; ns, not significantly different versus CTL 6.5. Bars  10 m.
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tion. Thus, in this study, we propose that the apical accumu-
lation of V-ATPase generated by the PBP10 peptide at acidic
pH was secondary to the induction of a less polymerized actin
cytoskeleton. No additional effect of PBP10 was observed on
V-ATPase distribution at a luminal pH of 7.8, suggesting that
the actin cytoskeleton was already maintained in a more depo-
lymerized state via gelsolin at alkaline pH. These results indi-
cate a major role for gelsolin in modulating the intracellular
and plasma membrane distribution of V-ATPase.
Because PBP10 might also have affected other PIP2-related
events within the cells, especially the highly PIP2-dependent
PLC calcium signaling pathway (73), we examined the poten-
tial involvement of calcium and PLC in V-ATPase recycling.
Both chelation of calcium with BAPTA-AM and inhibition of
PLC by U-73122 significantly inhibited the apical accumula-
tion of V-ATPase induced by alkaline luminal pH. These re-
sults indicate the requirement of the PLC calcium signaling
pathway in this process. The effect of BAPTA-AM occurred
downstream of sAC since inhibition of V-ATPase accumulation
was also observed when BAPTA-AM was added in the presence
of CPT-cAMP. This ruled out the possibility that the effect of
BAPTA-AM on V-ATPase distribution was secondary to inhi-
bition of sAC, an enzyme that can also be regulated by calcium.
Importantly, these data also show that the effect of PBP10 was
not due to impairment of the PLC pathway. Indeed, opposite
results would have been expected if such an interaction had
occurred.
Our data indicate that active remodeling of the actin cy-
toskeleton by gelsolin plays a key role in V-ATPase recycling.
At alkaline luminal pH, maintenance of the actin cytoskeleton
in a depolymerized state by gelsolin would facilitate the apical
membrane mobilization of V-ATPase via 1) an increase in the
rate of V-ATPase exocytosis, 2) a decrease in the rate of V-
ATPase endocytosis, or 3) a combination of both processes. At a
luminal pH of 6.5, these processes would be reversed to facili-
tate internalization of the V-ATPase. Very little co-localization
of V-ATPase with HRP-labeled endosomes was observed under
control conditions at alkaline pH or in the presence of CPT-
cAMP (this study and Ref. 65), indicating that reduction of
V-ATPase endocytosis is an important event for its apical mem-
brane accumulation. In this respect, the V-ATPase resembles
another membrane protein, AQP2, for which inhibition of en-
docytosis either by depletion of membrane cholesterol (78) or by
expression of dominant-negative GTPase-deficient K44A dy-
namin (79) is sufficient to induce its plasma membrane accu-
mulation. Interestingly, numerous larger HRP-containing en-
dosomes not labeled for V-ATPase were seen at alkaline
luminal pH or upon CPT-cAMP exposure (Figs. 3B and 7E,
red). We postulated that this V-ATPase-independent endocytic
pathway is activated secondary to massive apical membrane
accumulation of V-ATPase to prevent an overly excessive in-
crease in the apical surface of the cell. This partially compen-
satory mechanism was previously proposed for other actively
recycling membrane proteins (80). Activation of the V-ATPase-
independent endocytic pathway would also contribute to the
increase in the number of V-ATPase molecules/unit length of
apical membrane that we observed at alkaline pH (65). Inter-
estingly, a decrease in the amount of internalized V-ATPase in
HRP-labeled endosomes was observed in epididymides per-
fused at pH 6.5 with PBP10, whereas numerous V-ATPase-
negative endosomes were detected (Fig. 7A), a situation similar
to that observed under control alkaline pH conditions. This
result indicates that whereas the V-ATPase-related endocytic
compartment was inhibited by PBP10, V-ATPase-independent
endocytosis was still taking place. Thus, depolymerization of
the actin cytoskeleton by PBP10 at acidic pH would favor the
apical accumulation of V-ATPase in a manner similar to that
induced at alkaline pH via inhibition of V-ATPase endocytosis.
This points to a specific role for gelsolin in inhibiting V-ATPase
endocytosis in response to alkaline pH, whereas V-ATPase-
unrelated endocytosis can still occur. Accordingly, a more de-
polymerized actin cytoskeleton produced by gelsolin action at
alkaline luminal pH would favor the apical accumulation of
V-ATPase, at least partially via reduction of endocytosis.
In addition, the significant V-ATPase apical accumulation
induced by PBP10 at acidic luminal pH, a condition under
which clear cells normally do not show maximal V-ATPase
surface expression, strongly suggests that depolymerization of
the actin cytoskeleton by PBP10 represents a sufficient trigger
for this process to occur. Other studies have shown that mod-
ulation of the actin cytoskeleton is important for the regulation
of AQP2 recycling (27) and that depolymerization of the actin
cytoskeleton is sufficient to induce its cell-surface accumula-
tion (25).
Interestingly, a complete redistribution of V-ATPase from
apical microvilli to intracellular vesicles was observed after a
period of 25 min in the presence of jasplakinolide at both acidic
and alkaline luminal pH. A corresponding inhibition of bafilo-
mycin-sensitive net proton secretion was detected under these
conditions using the self-referencing proton-selective electrode.
These results are compatible with increased endocytosis and/or
decreased exocytosis of the V-ATPase. A previous study has
shown an increase in basolateral endocytosis, but no effect of
jasplakinolide on apical endocytosis in Madin-Darby canine
kidney cells (70). In our study, no or very few HRP-labeled
endosomes, either stained or negative for V-ATPase, were de-
tected when HRP was added to the luminal perfusate for 15
min after a preincubation period of 10 min with jasplakinolide,
at which time most of the actin cytoskeleton was probably in a
very polymerized state. We hypothesized that the bulk of V-
ATPase internalization occurred during the jasplakinolide pre-
incubation period. This was confirmed by the complete intra-
cellular redistribution of V-ATPase that was observed after a
10-min incubation with jasplakinolide. At this time point,
cAMP failed to induce V-ATPase apical accumulation when
applied in the continued presence of jasplakinolide. We have
shown previously that cAMP can induce the apical membrane
re-insertion of V-ATPase that has been internalized following
acetazolamide treatment (65), and we proposed that cAMP can
stimulate V-ATPase exocytosis. In our present study, since
most of the V-ATPase had been internalized by jasplakinolide
prior to addition of cAMP, it appears that actin polymerization
inhibited the exocytosis of V-ATPase. Thus, complete internal-
ization of V-ATPase by jasplakinolide would result from the
initial activation of V-ATPase endocytosis, followed by the pro-
gressive inhibition of exocytosis. Similarly, actin polymeriza-
tion inhibits the exocytosis of amylase-containing vesicles in
pancreatic acinar cells (18), and expression of constitutively
active RhoA to induce actin polymerization inhibits vasopres-
sin-induced AQP2 membrane accumulation (25).
The mechanisms responsible for the apical membrane accu-
mulation of V-ATPase that occurs in response to alkaline lu-
minal pH or cAMP elevation are still not fully characterized.
None of the subunits of the V-ATPase have been shown to be
phosphorylated by protein kinase A (49, 50), which indicates
that an indirect mechanism might be involved in the cAMP-
induced apical accumulation of the pump. Interestingly, mod-
ulation of the actin cytoskeleton by cAMP has been proposed
for the regulation of several membrane transporters (81–86),
and phosphorylation of RhoA by protein kinase A, leading to
actin disassembly, was invoked in their regulation. In this
study, depolymerization of the actin cytoskeleton by cAMP,
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leading to inhibition of V-ATPase endocytosis, would be com-
patible with the apical accumulation of V-ATPase induced by
cAMP. Thus, cAMP would exert its action via both an increase
in V-ATPase exocytosis and a decrease in V-ATPase endocyto-
sis. Whether cAMP acts via modulation of the actin cytoskele-
ton or via an independent pathway or whether both processes
take place still remains to be elucidated.
Our results point to a significant role for gelsolin in regulat-
ing V-ATPase recycling via modulation of the actin cytoskele-
ton. The severing activity of gelsolin is strongly dependent on
intracellular calcium (37, 87, 88). Although high calcium con-
centrations were initially reported to be required for gelsolin
activation, a conformational switch that reduces considerably
the required concentrations of calcium to nanomolar ranges
has recently been described in villin (89), a protein homologous
to gelsolin (90, 91). It was proposed that both villin and gelsolin
are maintained in an autoinhibited conformation and that,
upon tyrosine phosphorylation, a conformational modification
occurs that reveals high affinity sites for calcium. This model is
in agreement with our results showing the absolute require-
ment of calcium for the alkaline pH-induced accumulation of
V-ATPase. To determine whether tyrosine phosphorylation is
involved in this process will require further studies. The cal-
cium requirement of gelsolin was shown to depend on pH (92),
but the pH necessary to regulate gelsolin in vitro is very low
(pH 6.0) and is unlikely to be reached intracellularly.
We (59) and others (55–58) have shown that the V-ATPase
interacts directly or indirectly with actin. V-ATPase binds to
F-actin, but not to G-actin, and in osteoclasts, internalization of
V-ATPase is correlated with increased interaction with actin
(56). We are currently investigating the possibility that the
interaction between V-ATPase and actin can also be modulated
in clear cells.
In conclusion, this study shows high expression of gelsolin in
clear cells of the epididymis and that modulation of the actin
cytoskeleton by gelsolin plays a key role in the regulation of
V-ATPase surface expression. As gelsolin is also expressed in
other cells expressing the V-ATPase in their plasma mem-
brane, including kidney intercalated cells and osteoclasts, we
propose that modulation of the actin cytoskeleton by this sev-
ering and capping protein represents a common mechanism by
which these cells can regulate their rate of proton secretion.
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